|

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

RECRUITINGSponsored by Memorial Sloan Kettering Cancer Center
Actively Recruiting
SponsorMemorial Sloan Kettering Cancer Center
Started2023-11-03
Est. completion2029-05-03
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
Locations8 sites

Summary

This is an observational study that will include both participants with relapsed/refractory Multiple Myeloma and their doctors. The purpose of this study is to gather information about the use of hematopoietic cell transplantation/HCT and B-cell maturation antigen /BCMS targeted chimeric antigen receptor/CAR autologous T-cell therapy.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

Patient

* Diagnosis of Multiple Myeloma after January 1, 2017.
* Karnofsky Performance Status \> 70%
* ≥ 2 lines of prior therapy
* Anticipated to start new a line of therapy for RRMM within the next 12 months
* Age 18-80 years of age.
* English or Spanish speaking.
* Willing to provide informed consent
* Willing to perform study procedures.

Physician Investigator

* Be a Co-Investigator
* Agree to comply with study procedures

Exclusion Criteria:

Patient

* Active CNS disease
* Patients who already have a definitive plan are to be excluded

Conditions2

CancerMultiple Myeloma

Locations8 sites

Hartford Healthcare Alliance
Hartford, Connecticut, 06102
Mark Dailey, MD860-249-6291
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, 07920
Heather Landau, MD212-639-8808
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, 07748
Heather Landau, MD212-639-8808
Memorial Sloan Kettering Bergen
Montvale, New Jersey, 07645
Heather Landau, MD212-639-8808
Memorial Sloan Kettering Commack
Commack, New York, 11725
Heather Landau, MD212-639-8808

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.